Literature DB >> 10225508

Eye Movement Desensitization and Reprocessing: an analysis of specific versus nonspecific treatment factors.

J M Lohr1, S O Lilienfeld, D F Tolin, J D Herbert.   

Abstract

Incremental validity and incremental efficacy have become important issues in the evaluation of psychological assessment and intervention procedures. Incremental validity in assessment is that shown by novel measures over and above established ones. Incremental efficacy is that shown by novel treatments over and above nonspecific and established treatment effects. In this paper, we critically examine the question of whether Eye Movement Desensitization and Reprocessing (EMDR) possesses efficacy above and beyond nonspecific treatment effects and components that are shared with well-established interventions. A review of recently published efficacy studies reveals that (a) the effects of EMDR are largely limited to verbal report indices, (b) eye movements and other movements appear to be unnecessary, and (c) reported effects are consistent with nonspecific treatment features. Examination of individual studies shows that control procedures for nonspecific features have been minimal. We analyze EMDR for nonspecific treatment features and suggest experimental controls to examine the incremental efficacy of EMDR.

Mesh:

Year:  1999        PMID: 10225508     DOI: 10.1016/s0887-6185(98)00047-4

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  3 in total

1.  Evidence Searching for Evidence-based Psychology Practice.

Authors:  Louise Falzon; Karina W Davidson; Daniel Bruns
Journal:  Prof Psychol Res Pr       Date:  2010-12

2.  Exploring expectation effects in EMDR: does prior treatment knowledge affect the degrading effects of eye movements on memories?

Authors:  Marianne Littel; Kevin van Schie; Marcel A van den Hout
Journal:  Eur J Psychotraumatol       Date:  2017-06-19

3.  Facilitating access to emotions: neural signature of EMDR stimulation.

Authors:  Deborah Herkt; Visal Tumani; Georg Grön; Thomas Kammer; Arne Hofmann; Birgit Abler
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.